X-Ray Diffraction (XRD) is a technique used in the pharmaceutical industry to analyze crystal structures. It involves using x-rays to diffract off the planes of atoms in a crystal. By analyzing the angles and intensities of the diffracted x-rays, properties of the crystal such as its unit cell, polymorphism, purity, and compatibility with excipients can be determined. These properties have important implications for drug development, manufacturing, and quality control in the pharmaceutical industry.

1. X-Ray Diffraction (XRD)
IN PHARMACEUTICAL
Industry
Presented by :
SWASTIK JYOTI PAL
Roll no-19320318001
M.Pharm 1st yr(2018-20)
Bengal School of Technology
Hooghly,West Bengal1

2. “X-Rays”
• X-rays were discovered in 1895 by German Scientist
William Röntgen.
• X-RAYS are part of electromagnetic spectrum with
wavelength shorter than visible light.
• Most X-Rays have wavelength ranging from 0.01 to 10
nm.
2
Fig 1-position of x ray in electromagnetic spectrum

3. X-ray Crystallography
 A tool used for identifying the atomic and molecular structure
of a crystal, in which the crystalline atoms cause a beam of
incident X-rays to diffract into many specific directions.
 Measuring the angles and intensities of these diffracted
beams, a crystallographer can produce a three-dimensional
picture of the density of electrons within the crystal.
 From this electron density, the mean positions of the atoms in
the crystal can be determined, as well as their chemical bonds,
their disorder and various other information.
 Why only x-ray are used? Because x-rays have wavelengths of
about the same magnitude as the distance between the atoms or
molecules of crystal.
4

4. Crystals and Lattice
A. Crystallography involves the general consideration of how
crystals can be built from small units.
B. This corresponds to the infinite repetition of identical
structural units (frequently referred to as a unit cell) in space.
C. In other words, the structure of all crystals can be described
by a lattice, with a group of atoms allocated to every lattice
point.
D. Based on edge length and axial angle there are 14 Bravis
lattice .
4
Fig 2- a unit
cell

5. How are diffraction patterns made?
When X-rays are
scattered from a
crystalline solid they
can constructively
interfere , producing a
diffracted beam.
5
Fig 3-constructive vs destructive
interference

6. Bragg’s Diffraction
• Diffraction from a three dimensional periodic structure such
as atoms in a crystal is called Bragg Diffraction.
• Consequence of interference between waves reflecting
from different crystal planes.
• Constructive interference is given by Bragg's law:
• Where λ is the wavelength, d is the distance between crystal
planes, θ is the angle of the diffracted wave. and n is an
integer known as the order of the diffracted beam.
nλ = 2d sin θ
6

7. n‫2=גּ‬d.sinθ
Where,
n: an integer
d: interplanar distance
of crystal
θ: Bragg Angle
7
If the distance DE+EF=nλ, where n is an
integer , the scattered radiation will be
in phase and the crystal will appear to
reflect the x ray.
But,
DE=EF=d sin θ
Thus, nλ=2d sinθ
Fig 4-Braggs law explaining diffraction through
crystal

8. X-ray Generation
At the level of electrons-
1. Expulsion of electrons
from one of the lower
quantum
2. Vacancy filled by an
electron from upper
shell.
3. Emission of photon.
8
X rays are produced
whenever high speed
electrons collide with a
metal target .
A source of electrons – hot
Tungsten filament,a high
accelerating voltage
between the cathode(W)
and the anode and a metal
target (Cu,Al,Mo,Mg).
The anode is water cooled
block of Cu containing
desired target metal

9. 9
Fig 5-schematic diagram of an
X ray tube
Fig 6- X ray generation
at electronic level

10. Diffraction Methods
10
X ray diffraction
methods
Laue method
Transmission
method
Back reflection
method
Rotating crystal
method
Powder method

11. 11
Fig 7-A typical working diagram of a
X-ray diffractometer

12. APPLICATIONS IN
PHARMACEUTICAL
INDUSTRY:
12

13. 1.DRUG DEVELOPMENT:
• XRD provides details on degree of crystallinity and
amorphous content of synthetic mixtures.
• Crystalline impurities present can be quantified
down to 0.05% levels.
• XRD data is accepted for new product registrations
and patent applications.
• Single crystal structure of the active ingredient
and powder pattern of the finished formulation are
essential prerequisites for registration of new
patents.
13

14. 2.CRYSTAL STRUCTURE ANALYSIS– the lattice
type and dimensions of a unit cell need to be
specified for the crystalline content.
Diffraction patterns: When you shine a light beam
through a crystal, you get a distinctive pattern of
bright spots called a diffraction pattern. This pattern
is actually three dimensional.
Information from a diffraction pattern-
• Phase Identification
• Crystal Size
• Crystal Quality
• Texture (to some extent)
• Crystal Structure
14

15. 15
• Peak positions determined by size and shape of unit cell
• Peak intensities determined by the atomic number and
position of the various atoms within the unit cell
• Peak widths determined by instrument parameters ,
temperature, and crystal size, strain, and imperfections
Fig 8- XRD
graphs

16. 16
3.POLYMORPHISM -polymorphic content can impact
properties such as solubility and dissolution rate,
bioavailability and stability so it is important to collect
details on polymorphic properties of ingredients of a
drug material
Fig 9-XRD
patterns of (a)
crystalline and
(b) amorphous
sucrose

17. 17
4.PERCENTAGE OF CRYSTALLINITY– the
percent crystallinity is a valuable parameter for
drug dosage form. It has significant influence
on manufacturing and processing as well as the
pharmacological behaviour.
5. COMPATIBILITY WITH EXCIPIENTS-
makes it an ideal choice for studies on active
drug- excipient combinations. A detailed study
of the chosen excipients with active
pharmaceutical ingredient is a must for
consistency of properties such as drug release
and bio- availability.

18. 6. MANUFACTURING PROCESS CONTROL-
Manufacturing process can involve morphological changes in
crystalline phase due to introduction of stress forces. Such
changes can influence a drug’s bioavailability
The nondestructive nature of XRD analysis makes it an ideal
choice to fix the safe tableting pressure range so that the
dosage form achieves its targeted dissolution rate and bio
availability.
7. IDENTIFICATION OF IMPURITIES-
X-ray diffraction pattern of any specimens match with standard
Presence of Additional lines on the photograph of specimen,
indicate the presence of impurity.
e.g In cosmetic talc, the contaminant tremolite (a potentially
carcinogen ) can be detected by x-ray diffraction technique.
18

19. CONCLUSION
X-ray Diffraction is a very useful to characterize materials as it is:
1. A non destructive and easy method
2. X rays are not much absorbed by air,so the specimen need not to
be in an evacuated chamber .
3. This method is less expensive than other instrumental analysis
methods.
4. Requires minimal sample preparations.
5. Applicable over a wide range of samples.
6. Spectra obtained are simple and easy to interpret.
19

20. 1.Waseda Y,Matsubara E,Shinoda K. X-Ray Diffraction
Crystallography-Introduction, Examples and Solved Problems.
London, New York:Springer ; 2011 ;p.– 1-5,21-25.
2.Hammond C. The basics of crystallography and diffraction.
Third edition . New York : Oxford University Press ; 2011 ;p. 210-
215.
3.Ladd M,Palmer R . Structure determination - x ray
crystallography . Fifth edition . New York, London:Springer ;
2013 ; p.190-220.
4.Skoog D,Holler F,Crouch S. Principles of instrumental analysis.
Sixth edition. Australia:Thomson publication ;2007;p. 309-310.
REFERENCE
20

21. 21
THANK
YOU!!!